Cargando…
Successful management of steroid‐resistant vascular tumors associated with the Kasabach–Merritt phenomenon using sirolimus
Vascular tumors associated with Kasabach–Merritt phenomenon (KMP) are life‐threatening and the mortality is as high as 10–30%. Steroids are considered the primary choice for drug therapy. However, there are many steroid‐resistant cases. In the present study, analyzed data are presented to support th...
Autores principales: | Tan, Xiaoyun, Zhang, Jing, Zhou, Shaoyi, Liu, Zhenyin, Zhang, Tao, Xia, Jiejun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947617/ https://www.ncbi.nlm.nih.gov/pubmed/29356076 http://dx.doi.org/10.1111/1346-8138.14231 |
Ejemplares similares
-
Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon
por: Alaqeel, Alaa M., et al.
Publicado: (2016) -
Sirolimus for Kaposiform Hemangioendothelioma and Kasabach-Merritt Phenomenon in a Neonate
por: Cabrera, Trevor B., et al.
Publicado: (2020) -
Cocktail therapy with prednisolone, vincristine and sirolimus for Kasabach‑Merritt phenomenon in 10 infants
por: Liu, Qianlong, et al.
Publicado: (2022) -
Neonatal Kasabach-Merritt phenomenon
por: Yadav, Dinesh, et al.
Publicado: (2011) -
Kaposiform haemangioendothelioma with Kasabach - Merritt phenomenon
por: Jandial, Aditya, et al.
Publicado: (2020)